about
Redox-directed cancer therapeutics: molecular mechanisms and opportunitiesImplications for Damage Recognition during Dpo4-Mediated Mutagenic Bypass of m1G and m3C LesionsTherapy-related myeloid neoplasms - what have we learned so far?Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsMutational signatures of ionizing radiation in second malignanciesHow cancer shapes evolution, and how evolution shapes cancerMyeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer ChemotherapyChanges in allelic imbalances in locally advanced breast cancers after chemotherapy.Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemiaRosa26-GFP direct repeat (RaDR-GFP) mice reveal tissue- and age-dependence of homologous recombination in mammals in vivo.Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiationAssessing the risk of second malignancies after modern radiotherapyXRCC1 deficiency influences the cytotoxicity and the genomic instability induced by Me-lex, a specific inducer of N3-methyladenine.The role of senescent cells in ageing.Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesisClinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up studyUnusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.Role of MGMT as biomarker in colorectal cancer.DNA topoisomerases participate in fragility of the oncogene RET.Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressorDevelopment of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy.Genetic pathways leading to therapy-related myeloid neoplasms.Myeloid neoplasms after breast cancer: "therapy-related" not an independent poor prognostic factor.Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.Selective inhibition of DNA replicase assembly by a non-natural nucleotide: exploiting the structural diversity of ATP-binding sitesMolecular pathogenesis of secondary acute promyelocytic leukemiaSecond malignancies among elderly survivors of cancer.Biological response of cancer cells to radiation treatment.Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cellsSecond malignancies after multiple myeloma: from 1960s to 2010s.The role of fragile sites in sporadic papillary thyroid carcinomaQuantitative phosphoproteomics identifies filaggrin and other targets of ionizing radiation in a human skin model.Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Impact of Charged Particle Exposure on Homologous DNA Double-Strand Break Repair in Human Blood-Derived Cells.Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell LymphomaSecond primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
P2860
Q24645584-ED4F0494-058B-4687-A2B1-2B4C9EBDC0C5Q27668173-06A042D0-0C4C-4700-A60D-CF54599E3D27Q28071318-E6C22B82-09BA-47A1-BB22-9F2E2520B7DEQ28386366-524C9BAE-4302-4911-915F-17F88C454570Q28389573-D7184705-709F-4B69-A13E-1D3C70CDBCD9Q28688052-8173CF87-BA32-4ED3-9594-0CDC707E8E3FQ28818421-E1F45CAD-6939-4621-A301-696FB13C7616Q33299319-BABC9DAD-F1CF-4571-AF5D-21112675BBD9Q33435191-21EC2F47-A7BB-4068-BFD8-68DCAE751C74Q33597526-CAF89272-B83E-4F49-901F-8C3CFB8B7D5AQ33716551-AE3AB686-B3A9-4BA3-9FD5-3F007A8EB5FEQ33770167-58C017E0-4AA2-48AB-80E9-119A9D5CFDB3Q33914324-FC38B181-7E09-4B76-94AE-FE776299FBDAQ33945665-4D0E5EFA-E1D6-4C8F-B4DD-2849125CBCC2Q34041036-17BA276B-22FD-4381-9311-EA338A6C492DQ34076936-2BA5A434-D771-4A06-B263-E462CFD6DF59Q34236096-8E12201A-FA90-4F18-892F-ADA4EA2E7A20Q34425602-1C9C41EE-251C-494F-B6BD-1A62DBC7F51AQ34568905-C6ED7869-CF5D-4096-9154-ECF490E5DCD6Q34706115-FD84526F-FFF0-4AD7-998E-0716E8E29EE5Q34990644-4F9076E7-6D4A-4B65-AC39-BB897752A796Q34996082-7090ABDD-1E1D-441A-847B-A765F0100D6AQ35028204-9148B139-38E6-4027-A5E7-075A88FF084EQ35039992-0ACF8F8D-E185-4F19-B049-314A47EA1EA3Q35079660-FA2AB192-C921-4571-99CC-D2A844741A65Q35198383-51EA067A-63FB-4635-B54D-2499BB475B9AQ35203594-2109D538-B5BB-46CF-97DC-4078291830AAQ35560260-968E7340-EDC1-4098-817E-94C85B779DCAQ35599802-78A7A424-7150-4CF9-8E74-8B0DD78F9C83Q35600132-A7A071E2-3984-45C1-8BD2-4E90B6B2C538Q35793591-7AAAE356-3194-4557-849E-4529989B2DBDQ35891594-B4AF6961-42F0-4305-85EE-4D710E5DF0CEQ36063579-61E0B3C4-BCA0-4B40-9688-52E2E7F99B5AQ36070965-12208532-5BA7-433A-AAA3-F840EEFBC5D1Q36126599-B3E85E75-4589-47A9-ADE1-49187779DBFFQ36270627-BC767C0A-027F-4F9F-A2AC-F15508F75BF5Q36274109-A503964A-D2EF-4BA8-A54F-0DA8A08ADE9CQ36335336-EBA4482B-9A20-4E00-A147-D85CBBBE9630Q36522482-DADA98C0-B5C4-4A62-A6EC-642C02F07483Q36611922-B6DC8805-6E2E-441C-B815-8372BE204DCC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mechanisms of therapy-related carcinogenesis.
@ast
Mechanisms of therapy-related carcinogenesis.
@en
type
label
Mechanisms of therapy-related carcinogenesis.
@ast
Mechanisms of therapy-related carcinogenesis.
@en
prefLabel
Mechanisms of therapy-related carcinogenesis.
@ast
Mechanisms of therapy-related carcinogenesis.
@en
P2860
P356
P1476
Mechanisms of therapy-related carcinogenesis.
@en
P2093
James M Allan
Lois B Travis
P2860
P2888
P304
P356
10.1038/NRC1749
P407
P577
2005-12-01T00:00:00Z